Current Affairs

Avesthagen to Use Affymetrix Microarrays in Parsi Study

Affymetrix signed an agreement with Avesthagen for the use of its microarray technology in The AvestaGenome Project™, a genetic study of over 60,000 Parsi individuals. Based in India, the project aims at exploring the genetic basis of longevity and creating a genetic, genealogic, and medical database of the Parsi-Zoroastrian population.

The project is designed to discover biomarkers and drug targets that can result in predictive, preventive, and personalized healthcare. The Parsi community was selected because of its longevity and its relatively genetically homogeneous population. Thirty-one percent of the Parsi population lives beyond the age of 60, compared to 7% nationally, Avesthagen reports.

Complete press release here

Related Posts

Decoding the longevity DNA of Parsis :
The Avestagenome project, that seeks to plot the genetic and medical database of the Parsi community...

Inbred Investment Eyes Genomes :
Bangalore-based biotech firm Avesthagen is studying an inbred Indian population. Bangalore-based bio...

Avesthagen and Mallika Sarabhai present “And They Came to India” :
Avesthagen Limited, India's leading Life Sciences Company brings to you, in association with Mallika...

Avesthagen initiates Parsi genome project :
Avestha Gengraine Technologies (Avesthagen), a Bangalore-based integrated biotech company, has launc...

What is the secret behind the Parsi-Zoroastrians’ longevity? :
Bangalore-based biotech company trying to solve riddle opens Pune chapter, seeks blood samples Ba...